Eli Lilly & Co. (LLY)

1076.82 +5.18 (+0.48%) USD  |  NYSE  |  Dec 24, 12:59
1077.00 +0.18 (+0.02%) After-Hours: 13:59
More

Eli Lilly Cash and Short Term Investments (Annual): 3.423B for Dec. 31, 2024

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Amgen, Inc. 11.97B
Regeneron Pharmaceuticals, Inc. 9.012B
Adverum Biotechnologies, Inc. 125.69M
Viking Therapeutics, Inc. 902.61M
Moderna, Inc. 7.026B